Most investors are said to be positioned defensively. “Cash balances for EU funds were historically elevated at the start of ...

BEIRUT (Reuters) -Thousands of Syrian refugees are set to return from Lebanon this week under the first, U.N.-backed plan ...

A recent survey by Natixis Investment Managers found that 71% of strategists expect continued volatility in equity markets, ...

Looking ahead, Morgan Stanley now expects a sequential decline in the third quarter. “September quarter notebook ODM builds ...

The bank lowered its year-end EUR/CHF target to 0.9400, tempering expectations that SNB policy would drive the euro higher ...

Investing.com -- UBS has adjusted its forecast for the pound sterling, setting a new end-Q3 target of 0.8700 for the EUR/GBP ...

Investing.com -- Enphase Energy (NASDAQ: ENPH) stock fell 4% after Goldman Sachs analyst Brian Lee downgraded the solar ...

Investing.com -- J.P. Morgan has upgraded Genuit Group (LON: GENG) to “overweight” from “neutral” and increased its price target to 490p from 450p, updating its valuation to December 2026. The upgrade ...

Investing.com -- FTSE 100 companies are projected to post a 6% year-on-year decline in first-half 2025 earnings, with the Energy sector expected to be the largest drag, according to Deutsche Bank’s ...

Investing.com -- Tandem Diabetes Care (NASDAQ: TNDM) stock fell 5% Wednesday morning after Citi downgraded the medical device maker to Sell from Neutral, citing intensifying competitive pressures.

The adjustment reflects changing relative outlooks between the Riksbank and the European Central Bank. The Riksbank began the year with guidance for a terminal rate of 2.25%, which it reached in ...

Investing.com -- Merck (NSE: PROR) said on Wednesday it has entered into a definitive agreement to acquire Verona Pharma PLC ADR (NASDAQ: VRNA) for $107 per American Depository Share, representing a ...